2 results
Approved WMOCompleted
The primary objective is to determine the efficacy of pain control with this type of Peripheral Subcutaneous Field Stimulation (PSFS) at three months and 12 months. The secondary objectives determined at both 3 and 12 months are the assessment of…
Approved WMOCompleted
Primary Objective:1. To evaluate the efficacy of sonelokimab at 2 different dose levels (120 mg, 240 mg) compared with placebo in the treatment of participants withactive moderate to severe hidradenitis suppurativa.Secondary Objectives:1. To…